{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:18:38Z","timestamp":1791389918492,"version":"4.3.3"},"reference-count":50,"publisher":"The Journal of Rheumatology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate risk factors and characteristics of active tuberculosis (TB) in biologic-na\u00efve patients with rheumatoid arthritis (RA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a population-based case-control study using the Swedish Rheumatology Quality Register, the National Patient Register, and the Tuberculosis Register to identify RA patients with active TB and matched RA controls without TB between 2001\u20132014. Clinical data were obtained from medical records. TB risk was estimated as adjusted OR (aOR) with 95% CI using univariate and multivariable logistic regression analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After validation of diagnoses, the study included 31 RA patients with TB and 122 matched RA controls. All except 3 cases had reactivation of latent TB. Pulmonary TB was most prevalent (84%). Ever use of methotrexate was not associated with increased TB risk (aOR 0.8, 95% CI 0.3\u20132.0), whereas ever treatment with leflunomide (aOR 6.0, 95% CI 1.5\u201324.7), azathioprine (aOR 3.8, 95% CI 1.1\u201313.8), and prednisolone (PSL; aOR 2.4, 95% CI 1.0\u20136.0) was. There were no significant differences between maximum dose of PSL, treatment duration with PSL before TB, or cumulative dose of PSL the year before TB diagnosis between cases and controls. Obstructive pulmonary disease was associated with an increased TB risk (aOR 3.9, 95% CI 1.5\u201310.7).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Several RA-associated factors may contribute to increased TB risk in biologic-na\u00efve patients with RA, making the risk of TB activation difficult to predict in the individual patient. To further decrease TB in patients with RA, the results suggest that screening for latent TB should also be considered in biologic-na\u00efve patients.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.201251","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T12:24:32Z","timestamp":1617279872000},"page":"1243-1250","source":"Crossref","is-referenced-by-count":19,"title":["Tuberculosis in Biologic-na\u00efve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics"],"prefix":"10.3899","volume":"48","author":[{"given":"Johanna Karlsson","family":"Sundbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3677-9736","authenticated-orcid":false,"given":"Elizabeth V.","family":"Arkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1383-6176","authenticated-orcid":false,"given":"Jerker","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Baecklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"2022062114102975000_48.8.1243.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"2022062114102975000_48.8.1243.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120165"},{"key":"2022062114102975000_48.8.1243.3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102975000_48.8.1243.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204960"},{"key":"2022062114102975000_48.8.1243.5","first-page":"706","article-title":"Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers","volume":"34","author":"Seong","year":"2007","journal-title":"J Rheumatol"},{"key":"2022062114102975000_48.8.1243.6","first-page":"1436","article-title":"Increased risk of tuberculosis in patients with rheumatoid arthritis","volume":"30","author":"Carmona","year":"2003","journal-title":"J Rheumatol"},{"key":"2022062114102975000_48.8.1243.7","doi-asserted-by":"publisher","DOI":"10.1157\/13045537"},{"key":"2022062114102975000_48.8.1243.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.21519"},{"key":"2022062114102975000_48.8.1243.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.24476"},{"key":"2022062114102975000_48.8.1243.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.27268"},{"key":"2022062114102975000_48.8.1243.11","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206470"},{"key":"2022062114102975000_48.8.1243.12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/2168479017728987","article-title":"Comparison of serious adverse event profiles among antirheumatic agents using Japanese adverse drug event report database","volume":"52","author":"Matsuoka","year":"2018","journal-title":"Ther Innov Regul Sci"},{"key":"2022062114102975000_48.8.1243.13","doi-asserted-by":"publisher","DOI":"10.1086\/506935"},{"key":"2022062114102975000_48.8.1243.14","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-012-0716-8"},{"key":"2022062114102975000_48.8.1243.15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/tid.12555","article-title":"Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use","volume":"18","author":"Guirao-Arrabal","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"2022062114102975000_48.8.1243.16","first-page":"9","article-title":"Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population","volume":"16","author":"Kim","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"2022062114102975000_48.8.1243.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.21705"},{"key":"2022062114102975000_48.8.1243.18","first-page":"881","article-title":"Incidence of tuberculosis among patients receiving treatment with oral corticosteroids","volume":"48","author":"Agrawal","year":"2000","journal-title":"J Assoc Physicians India"},{"key":"2022062114102975000_48.8.1243.19","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0031"},{"key":"2022062114102975000_48.8.1243.20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejim.2017.05.020","article-title":"Nation-based case-control study investigating the relationship between oral corticosteroids use and pulmonary tuberculosis","volume":"43","author":"Lai","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2022062114102975000_48.8.1243.21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450"},{"key":"2022062114102975000_48.8.1243.22","unstructured":"Forsberg L , Rydh H , Jacobsson A , Nyqvist K , Heurgren M. Kvalitet och inneh\u00e5ll i patientregistret. [Utskrivningar fr\u00e5n slutenv\u00e5rden 1964-2007 och bes\u00f6k i specialiserad \u00f6ppenv\u00e5rd (exklusive prim\u00e4rv\u00e5rdsbes\u00f6k) 1997-2007]. (Quality and content of the Patient Register)[Document in Swedish. Internet. Accessed May 20, 2021.] Available from www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/statistik\/2009-125-15_200912515_rev2.pdf"},{"key":"2022062114102975000_48.8.1243.23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-432"},{"key":"2022062114102975000_48.8.1243.24","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2014.941919"},{"key":"2022062114102975000_48.8.1243.25","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"2022062114102975000_48.8.1243.26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00201609"},{"key":"2022062114102975000_48.8.1243.27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel130"},{"key":"2022062114102975000_48.8.1243.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056283"},{"key":"2022062114102975000_48.8.1243.29","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.6.987"},{"key":"2022062114102975000_48.8.1243.30","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.11.841"},{"key":"2022062114102975000_48.8.1243.31","first-page":"5","article-title":"Reactivation of tuberculosis by tumor necrosis factor neutralization","volume":"18","author":"Jacobs","year":"2007","journal-title":"Eur Cytokine Netw"},{"key":"2022062114102975000_48.8.1243.32","doi-asserted-by":"crossref","first-page":"e0194430","DOI":"10.1371\/journal.pone.0194430","article-title":"TNF-alpha blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines","volume":"13","author":"Silva","year":"2018","journal-title":"PLoS One"},{"key":"2022062114102975000_48.8.1243.33","first-page":"305","article-title":"Specific acquired resistance and activity of migration inhibition factor (MIF) in spleens of mice with chronic tuberculosis","volume":"56","author":"Kvapilov\u00e1","year":"1975","journal-title":"Scand J Respir Dis"},{"key":"2022062114102975000_48.8.1243.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010138"},{"key":"2022062114102975000_48.8.1243.35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tube.2015.08.005","article-title":"TB meets COPD: an emerging global co-morbidity in human lung disease","volume":"95","author":"O\u2019Toole","year":"2015","journal-title":"Tuberculosis"},{"key":"2022062114102975000_48.8.1243.36","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201007-1099OC"},{"key":"2022062114102975000_48.8.1243.37","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2147\/COPD.S179609","article-title":"Prevalence of malnutrition in COPD and its relationship with the parameters related to disease severity","volume":"13","author":"Mete","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2022062114102975000_48.8.1243.38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2018.05.003","article-title":"Malnutrition is associated with diminished baseline and mycobacterial antigen \u2013 stimulated chemokine responses in latent tuberculosis infection","volume":"77","author":"Anuradha","year":"2018","journal-title":"J Infect"},{"key":"2022062114102975000_48.8.1243.39","doi-asserted-by":"crossref","first-page":"e0214011","DOI":"10.1371\/journal.pone.0214011","article-title":"Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis","volume":"14","author":"Hoyt","year":"2019","journal-title":"PLoS One"},{"key":"2022062114102975000_48.8.1243.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2014.08.010"},{"key":"2022062114102975000_48.8.1243.41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/OARRR.S218448","article-title":"A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis \u2013 results of clinical relevance","volume":"11","author":"Hafstr\u00f6m","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"2022062114102975000_48.8.1243.42","doi-asserted-by":"publisher","DOI":"10.1038\/35047123"},{"key":"2022062114102975000_48.8.1243.43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2169\/internalmedicine.53.1936","article-title":"Characteristics of tuberculosis in patients with rheumatoid arthritis: a retrospective single-center study","volume":"53","author":"Ishiguro","year":"2014","journal-title":"Intern Med"},{"key":"2022062114102975000_48.8.1243.44","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1038\/s41598-019-49439-9","article-title":"Predictors for pulmonary tuberculosis treatment outcome in Denmark 2009-2014","volume":"9","author":"Holden","year":"2019","journal-title":"Sci Rep"},{"key":"2022062114102975000_48.8.1243.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004818"},{"key":"2022062114102975000_48.8.1243.46","first-page":"24","article-title":"Delayed tuberculosis diagnosis and tuberculosis transmission","volume":"10","author":"Golub","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2022062114102975000_48.8.1243.47","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0683"},{"key":"2022062114102975000_48.8.1243.48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022445"},{"key":"2022062114102975000_48.8.1243.49","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070789"},{"key":"2022062114102975000_48.8.1243.50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5578\/tt.66122","article-title":"TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy","volume":"66","author":"Sarg\u0131n","year":"2018","journal-title":"Tuberk Toraks"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.201251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T21:19:03Z","timestamp":1655846343000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.201251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,1]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.3899\/jrheum.201251"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.201251","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}